[Federal Register Volume 67, Number 32 (Friday, February 15, 2002)]
[Notices]
[Page 7205]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-3686]


-----------------------------------------------------------------------

NATIONAL AERONAUTICS AND SPACE ADMINISTRATION

[Notice 02-025]


Notice of Prospective Patent License

AGENCY: National Aeronautics and Space Administration.

ACTION: Notice of prospective patent license.

-----------------------------------------------------------------------

SUMMARY: NASA hereby gives notice that Critical Care Innovations, Inc. 
having offices in Chantilly, Virginia, has applied for a partially 
exclusive license to practice the inventions described and claimed in 
U.S. Patent No. 5,827,531, entitled ``Multi-Lamellar, Immiscible-Phase 
Microencapsulation of Drugs''; U.S. Patent No. 6,099,864, entitled 
``INSITU Activation of Microcapsules''; U.S. Patent No. 6,214,300, 
entitled ``Microencapsulation and Electrostatic Processing Device 
(MEPS)''; U.S. Patent No. 6,103,271, entitled ``Microencapsulation & 
Electrostatic Coating Process''; pending U.S. Patent Application 
entitled ``Protein Crystal Encapsulation Process'', NASA Case No. MSC-
22936-1-SB; pending U.S. Patent Application entitled ``Externally 
Triggered Microcapsules'', NASA Case No. MSC-22939-1-SB and pending 
continuations, divisional applications, and foreign applications 
corresponding to the above-listed cases. Each of the above-listed 
patents and patent applications are assigned to the United States of 
America as represented by the Administrator of the National Aeronautics 
and Space Administration. Written objections to the prospective grant 
of a license should be sent the Johnson Space Center.

DATES: Responses to this notice must be received by March 4, 2002.

FOR FURTHER INFORMATION CONTACT: James Cate, Patent Attorney, NASA 
Johnson Space Center, Mail Stop HA, Houston, TX 77058-8452; telephone 
(281) 483-1001.

    Dated: February 8, 2002.
Robert M. Stephens,
Deputy General Counsel.
[FR Doc. 02-3686 Filed 2-14-02; 8:45 am]
BILLING CODE 7510-01-P